In a major step forward for cancer care in Ireland, gov.ie-aligned public health services have announced a new home-based treatment model through the Health Service Executive (HSE). HSE South West has launched a pioneering programme that allows eligible breast cancer patients to receive Herceptin treatment at home, reducing hospital visits and making ongoing care more manageable.
The new initiative, introduced through the Cancer Centre at Cork University Hospital (CUH), is the first service of its kind in Ireland. It enables suitable patients with HER-2 positive breast cancer to self-administer Herceptin at home after receiving training and clinical clearance. The development reflects a growing focus across Health, Social Protection and public service delivery on more person-centred, accessible treatment pathways.
HSE South West cancer treatment at home marks an Irish first
The Herceptin in the Home programme is designed for patients who are already stable on treatment and familiar with the medication. Herceptin is used to treat HER-2 positive breast cancer by helping stop cancer cells from spreading and assisting the body in destroying them. For many patients, it is prescribed as a long-term maintenance treatment after surgery, chemotherapy or radiotherapy, and is typically given every three weeks.
Under the new model, patients attend CUH for education on how to administer the injection themselves. They then complete blood tests locally through their GP. Once approved for treatment, the medication is delivered to their home by courier, stored safely in a refrigerator, and taken on the scheduled day.
- Less time spent travelling to and from hospital
- Fewer disruptions to work and childcare
- More flexibility around treatment schedules
- Continued clinical oversight with follow-up calls
This HSE South West cancer treatment at home programme is also expected to ease pressure on hospital capacity while improving quality of life for patients.
Why Herceptin in the Home matters for patients
For women who have been travelling to CUH every three weeks for years, the change is significant. Hospital appointments can involve long journeys, waiting times, traffic, parking costs and time away from family life. By shifting suitable care into the home, the HSE is helping patients reclaim time and independence without compromising safety.
Clinical leaders involved in the project say the programme could also help shape broader home-based Systemic Anti-Cancer Therapy pathways across Cork and Kerry. That makes this launch important not only for current patients, but for the future of regional cancer services in Ireland.
Read more: latest Irish health service updates and patient care news in Ireland | public health and hospital service developments across Ireland
Regional collaboration behind the HSE South West cancer treatment at home rollout
The programme has been developed through multidisciplinary co-operation across HSE South West and is backed by the National Cancer Control Programme. That support is significant because it signals a wider commitment to innovation in healthcare delivery, similar to how other Irish public bodies such as the Revenue Commissioners, Department of the Taoiseach, Finance, Housing, Justice, Education and Public Expenditure are increasingly focused on service modernisation.
While this announcement is rooted in Health policy, it also speaks to a broader government trend toward bringing services closer to communities. Agencies including the Citizens Information Board, HIQA, HPRA, CSO and the Data Protection Commission (DPC) all play important roles in the wider ecosystem of patient information, regulation, standards and accountability.
What happens next
HSE South West has indicated that lessons from this first-of-its-kind service may support a wider regional rollout across Cork and Kerry. There is also potential for similar home-based treatment pathways to be considered for other cancer therapies where clinically appropriate.
- Eligible patients are assessed by specialist teams
- Training is provided at CUH
- Local blood testing supports clinical monitoring
- Medication is delivered directly to the patient’s home
- Ongoing follow-up helps maintain safety and confidence
Explore more: Ireland health innovation and community care trends | breaking Ireland government press release and health sector news
What this means for cancer care in Ireland
The HSE South West cancer treatment at home launch is more than a local service update. It represents a practical shift in how long-term treatment can be delivered: safely, efficiently and with patients’ daily lives in mind. As Ireland continues to modernise public services through gov.ie and the Health Service Executive (HSE), this model may become a blueprint for future home-based care.
The clear takeaway is that HSE South West cancer treatment at home offers convenience, dignity and clinical support in one package — and it could reshape how cancer treatment is delivered across Ireland in the years ahead.
Article/Image Courtesy: HSE
